FDA
Gadoterate Meglumine
The FDA lists this product in 10 strengths and forms.
Composition
- Active ingredients
- GADOTERATE MEGLUMINE 1.8845GM/5ML (376.9MG/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- GADOTERATE MEGLUMINE 37.69GM/100ML (376.9MG/ML) · SolutionANDA218073-005 · Prescription
- GADOTERATE MEGLUMINE 5.6535GM/15ML (376.9MG/ML) · SolutionANDA218073-003 · Prescription
- GADOTERATE MEGLUMINE 1.8845GM/5ML (376.9MG/ML) · SolutionANDA218073-001 · Prescription
- GADOTERATE MEGLUMINE 7.538GM/20ML (376.9MG/ML) · SolutionANDA218073-004 · Prescription
- GADOTERATE MEGLUMINE 3.769GM/10ML (376.9MG/ML) · SolutionANDA218073-002 · Prescription
- GADOTERATE MEGLUMINE 37.69GM/100ML (376.9MG/ML) · SolutionANDA215304-005 · Discontinued
- GADOTERATE MEGLUMINE 5.6535GM/15ML (376.9MG/ML) · SolutionANDA215304-003 · Discontinued
- GADOTERATE MEGLUMINE 1.8845GM/5ML (376.9MG/ML) · SolutionThis page
- GADOTERATE MEGLUMINE 7.538GM/20ML (376.9MG/ML) · SolutionANDA215304-004 · Discontinued
- GADOTERATE MEGLUMINE 3.769GM/10ML (376.9MG/ML) · SolutionANDA215304-002 · Discontinued
At a glance
- Brand name
- Gadoterate Meglumine
- Route
- Intravenous
- Dosage form
- Solution
- Applicant
- Hengrui Pharma
- Status
- Discontinued
- FDA approval
- 11 Apr 2022
- Application
- ANDA215304-001